PURPOSE: For gay and bisexual men (GBM), research suggests that familiarity with Pre-Exposure Prophylaxis (PrEP) has been increasing since being approved by the U.S. FDA in 2012. However, it is less clear how willingness to start using PrEP has changed over time. Likewise, some have expressed concerns regarding the potential for risk compensation (i.e., reduced condom use) were one to start PrEP; however, again, it is unclear how these may have been changing over time. METHODS: We conducted baseline and 12 month assessments with 158 highly sexually active HIV-negative GBM in NYC who were assessed between 2011 and 2014. We examined change over time both between participants (based on when they entered the study), as well as within each parti...
Background: Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV tran...
Introduction: Daily and event-driven oral pre-exposure prophylaxis (PrEP) reduce the risk of HIV acq...
Criminal justice (CJ) settings disproportionately include populations at high risk for acquiring HIV...
PURPOSE: For gay and bisexual men (GBM), research suggests that familiarity with Pre-Exposure Prophy...
Once-daily Truvada (Emtricitabine/Tenofovir) as a method of pre-exposure prophylaxis (PrEP) is one o...
Pre-exposure prophylaxis (PrEP) has altered the public health landscape for gay, bisexual, and other...
This study explored familiarity with, attitudes toward, uptake and discontinuation of PrEP (Pre-expo...
Objectives: To investigate willingness to use HIV preexposure prophylaxis (PrEP) and the likelihood ...
Background - Pre-exposure prophylaxis (PrEP) provides protection against HIV transmission but not ag...
Gay, bisexual, and other men who have sex with men (GBM) are disproportionately affected by the HIV ...
This study examined HIV testing and use, familiarity, and attitudes toward pre-exposure prophylaxis ...
Objective: We conducted a mixed-methods study to examine serodiscordant and seroconcordant (HIV-posi...
OBJECTIVES: We considered how decision making around human immunodeficiency virus (HIV) pre-exposure...
IntroductionNotwithstanding the efficacy of oral preâ exposure prophylaxis (PrEP) in clinical trial...
BackgroundA public health concern regarding HIV pre-exposure prophylaxis (PrEP) is sexual risk compe...
Background: Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV tran...
Introduction: Daily and event-driven oral pre-exposure prophylaxis (PrEP) reduce the risk of HIV acq...
Criminal justice (CJ) settings disproportionately include populations at high risk for acquiring HIV...
PURPOSE: For gay and bisexual men (GBM), research suggests that familiarity with Pre-Exposure Prophy...
Once-daily Truvada (Emtricitabine/Tenofovir) as a method of pre-exposure prophylaxis (PrEP) is one o...
Pre-exposure prophylaxis (PrEP) has altered the public health landscape for gay, bisexual, and other...
This study explored familiarity with, attitudes toward, uptake and discontinuation of PrEP (Pre-expo...
Objectives: To investigate willingness to use HIV preexposure prophylaxis (PrEP) and the likelihood ...
Background - Pre-exposure prophylaxis (PrEP) provides protection against HIV transmission but not ag...
Gay, bisexual, and other men who have sex with men (GBM) are disproportionately affected by the HIV ...
This study examined HIV testing and use, familiarity, and attitudes toward pre-exposure prophylaxis ...
Objective: We conducted a mixed-methods study to examine serodiscordant and seroconcordant (HIV-posi...
OBJECTIVES: We considered how decision making around human immunodeficiency virus (HIV) pre-exposure...
IntroductionNotwithstanding the efficacy of oral preâ exposure prophylaxis (PrEP) in clinical trial...
BackgroundA public health concern regarding HIV pre-exposure prophylaxis (PrEP) is sexual risk compe...
Background: Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV tran...
Introduction: Daily and event-driven oral pre-exposure prophylaxis (PrEP) reduce the risk of HIV acq...
Criminal justice (CJ) settings disproportionately include populations at high risk for acquiring HIV...